Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Rigel Pharmaceuticals initiates Phase 3 studies of fostamatinib in ITP
Rigel Pharmaceuticals initiates Phase 3 studies of fostamatinib in ITP
Rigel Pharmaceuticals initiates Phase 3 studies of fostamatinib in ITP
Submitted by
admin
on July 16, 2014 - 10:42am
Source:
Yahoo/Fly on the Wall
News Tags:
fostamatinib
Rigel Pharmaceuticals
ITP
Headline:
Rigel Pharmaceuticals initiates Phase 3 studies of fostamatinib in ITP
Do Not Allow Advertisers to Use My Personal information
